Status:
COMPLETED
Assessment of Feasibility and Acceptability of Personalized Breast Cancer Screening
Lead Sponsor:
Institut de Recerca Biomèdica de Lleida
Collaborating Sponsors:
Institut Català de la Salut
Catalan Health Service
Conditions:
Breast Cancer
Eligibility:
FEMALE
40-50 years
Phase:
NA
Brief Summary
The overall objective is to assess the acceptability and feasibility of offering personalized breast cancer (BC) screening. The specific objectives are: 1) To design an information system; 2) To eval...
Eligibility Criteria
Inclusion
- Not having had a mammogram in the last 12 months or with a mammogram in this period available to evaluate breast density.
- Sign the informed consent.
Exclusion
- Previous diagnosis of breast cancer.
- Breast study in process.
- Fulfill clinical criteria defined by the Medical Oncology Spanish Society (SEOM to refer to the genetic counseling unit in cancer.
- Do not understand or speak Catalan or Spanish.
- Cognitive disability for mental or mental illness.
- Physical disability that prevents a mammogram.
Key Trial Info
Start Date :
January 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
387 Patients enrolled
Trial Details
Trial ID
NCT03791008
Start Date
January 30 2019
End Date
December 31 2021
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Recerca Biomèdica de Lleida
Lleida, Spain, 25198